Similarities in the pregabalin efficacy profiles, including time to onset and magnitude of response, were confirmed regardless of the neuropathic pain condition. These data support the potential for extrapolating analgesic efficacy to other neuropathic pain conditions. < /p > < /span > < span class= " a-plus-plus abstract-section id-a-sec5 " > < h3 c..."> Similarities in the pregabalin efficacy profiles, including time to onset and magnitude of response, were confirmed regardless of the neuropathic pain condition. These data support the potential for extrapolating analgesic efficacy to other neuropathic pain conditions. < /p > < /span > < span class= " a-plus-plus abstract-section id-a-sec5 " > < h3 c..." /> Similarities in the pregabalin efficacy profiles, including time to onset and magnitude of response, were confirmed regardless of the neuropathic pain condition. These data support the potential for extrapolating analgesic efficacy to other neuropathic pain conditions. < /p > < /span > < span class= " a-plus-plus abstract-section id-a-sec5 " > < h3 c..." />

Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions

Conclusion < /h3 > < p class= " a-plus-plus " > Similarities in the pregabalin efficacy profiles, including time to onset and magnitude of response, were confirmed regardless of the neuropathic pain condition. These data support the potential for extrapolating analgesic efficacy to other neuropathic pain conditions. < /p > < /span > < span class= " a-plus-plus abstract-section id-a-sec5 " > < h3 class= " a-plus-plus " > ClinicalTrials.gov identifiers < /h3 > < p class= " a-plus-plus " > NCT00394901, NCT00553475, NCT00407745, NCT00424372, NCT00553280, NCT01202227. < /p > < /span >
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research